Share Price | PaxMedica, Inc. Stock Analysis & Recommendation

Q: Is PaxMedica, Inc. technically bullish or bearish?

As of 1 July 2025, the technical trend for PaxMedica, Inc. has changed from sideways to mildly bearish. The daily moving averages indicate a mildly bearish stance, while the weekly MACD shows a mildly bullish signal. However, the KST is bearish on a weekly basis, and there are no clear trends in Dow Theory or OBV. Overall, the mixed signals suggest a bearish outlook, with the strength being mild. There is no available return data to compare the company's performance against the S&P 500.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.07 k

Shareholding (Sep 2024)

FII

0.00%

Held by 0 FIIs

DII

99.95%

Held by 0 DIIs

Promoter

0.00%

How big is PaxMedica, Inc.?

22-Jun-2025

As of Jun 18, PaxMedica, Inc. has a market capitalization of 0.00, classifying it as a Micro Cap company. As of Dec 23, it reported Shareholder's Funds of 3.39 Million and Total Assets of 5.68 Million.

View full answer

Is PaxMedica, Inc. technically bullish or bearish?

20-Sep-2025

As of July 1, 2025, PaxMedica, Inc. shows a mildly bearish trend with mixed signals from moving averages and indicators, suggesting a cautious outlook.

View full answer

Compare PaxMedica, Inc. with Similar Stocks

Lixte Biotechnology Holdings, Inc.ContraFect Corp.Exicure, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 0 Million ()

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.23

Return on Equity

-999,999.00%

Price to Book

-0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - Sep 2024)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-98.0%

6 Months

0.0%

1 Year

0.0%

2 Years

-99.98%

3 Years

-100.0%

4 Years

0.0%

5 Years

0.0%

PaxMedica, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-149.30%

EBIT to Interest (avg)

-2.16

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.18

Sales to Capital Employed (avg)

Tax Ratio

25.61%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

1.61%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

-0.00

EV to EBIT

0.02

EV to EBITDA

0.02

EV to Capital Employed

0.15

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

724.14%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Sideways

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2024

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (0.05%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Sep 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is 82.00% vs 56.52% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.90",
          "val2": "-4.40",
          "chgp": "79.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.90",
          "val2": "-5.00",
          "chgp": "82.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -23.65% vs -45.10% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-16.10",
          "val2": "-10.60",
          "chgp": "-51.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.90",
          "val2": "-4.10",
          "chgp": "53.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-18.30",
          "val2": "-14.80",
          "chgp": "-23.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY

Sep'24

Sep'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.90

-4.40

79.55%

Interest

0.00

Exceptional Items

0.00

-0.70

100.00%

Consolidate Net Profit

-0.90

-5.00

82.00%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Sep 2023

Consolidated Net Profit

YoY Growth in quarter ended Sep 2024 is 82.00% vs 56.52% in Sep 2023

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-16.10

-10.60

-51.89%

Interest

0.00

Exceptional Items

-1.90

-4.10

53.66%

Consolidate Net Profit

-18.30

-14.80

-23.65%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -23.65% vs -45.10% in Dec 2022

All Annual Results

Company CV

About PaxMedica, Inc.

PaxMedica, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

PaxMedica, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is PaxMedica, Inc.?

Watch in Real-Time

Is PaxMedica, Inc. technically bullish or bearish?

Compare PaxMedica, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2024

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY

Annual Results Snapshot (Consolidated) - Dec'23

About PaxMedica, Inc.

Company Coordinates